Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
SHISA9 Blocking Peptide (AC1301)
Cat.#: ACPP-1301
Specifications
Despition SHISA9 Blocking Peptide for Immunocompetition, Immunodepletion SIZE 250 µg Applications Immunodepletion & Immunocompetition assay Storage Store at -20⁰C for long term Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1261 TSH beta Blocking Peptide (AC1261) 250 µg inquiry ACPP-1338 Dopamine Receptor D1 Blocking Peptide (AC1338) 250 µg inquiry ACPP-1510 Human TIMP1 Protein, Sf9 (AC1510) 2 µg inquiry ACPP-1660 Mouse GDF7 Protein (AC1660) 2 µg inquiry ACPP-1007 Recombinant Human Secretogranin 3 Protein (6×His Tag) (AC1007) 50 µg inquiry ACPP-1657 Human CRCP Protein (AC1657) 5 µg inquiry ACPP-1638 Human CNTF Protein (AC1638) 5 µg inquiry ACPP-1596 Human SPG21 Protein (AC1596) 5 µg inquiry ACPP-1110 Recombinant Human ROR1 Protein (6×His Tag) (AC1110) 50 µg inquiry ACPP-1392 Human Dopa Decarboxylase Protein (AC1392) 5 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket